In this issue of JAMA Internal Medicine, Resnick and colleagues1 test the hypothesis that Medicare Accountable Care Organizations (ACOs) are associated with changes in cancer screening among beneficiaries. Accountable Care Organizations are intended to provide incentives for care coordination and promote high-quality care. In addition, measures for underuse of breast and colorectal cancer screening are routinely used to evaluate ACO quality of care. While no measures specifically address overuse of cancer screening, ACOs are responsible for downstream negative effects from overscreening—harms from the test, overdiagnosis, and overtreatment. Therefore, one would expect ACOs to increase cancer screening when appropriate and reduce cancer screening when inappropriate, reducing both underuse and overuse.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Lipitz-Snyderman A. Accountability for Underuse and Overuse of Cancer Screening. JAMA Intern Med. 2018;178(5):655–656. doi:10.1001/jamainternmed.2017.8086
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: